Form 4 for BCYC BICYCLE THERAPEUTICS PLC
Accepted 2021-12-22 00:00:00 ET · period of report 2021-12-21 · accession 0001209191-21-071008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-22 | 2021-12-21 | BCYC | Keen Nicholas | CSO | M - OptEx | $14.00 | +15.5K | 15.5K | New | +$216.7K |
| D | 2021-12-22 | 2021-12-21 | BCYC | Keen Nicholas | CSO | M - OptEx | $0.00 | -15.5K | 161.9K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-12-21 | M | A | 15,477 | $14.00 | 15,477 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-12-21 | M | D | 15,477 | $0.00 | 161,927 | D | $14.00 · — to 2029-06-28 | 15,477 Ordinary Shares | (F1) This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. |